These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19922751)

  • 1. Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
    du Toit LC; Pillay V; Choonara YE
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):532-46. PubMed ID: 19922751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
    das Neves J; Amiji MM; Bahia MF; Sarmento B
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):458-77. PubMed ID: 19914314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides for multidrug-resistant and multitropic HIV-1.
    D'Cruz OJ; Uckun FM
    Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical development of microbicide drug products.
    Friend DR
    Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based vaginal drug delivery systems for HIV prevention.
    Mallipeddi R; Rohan LC
    Expert Opin Drug Deliv; 2010 Jan; 7(1):37-48. PubMed ID: 20017659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ; Uckun FM
    Mol Hum Reprod; 2005 Oct; 11(10):767-77. PubMed ID: 16254003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing pills and patents: intellectual property and the HIV/AIDS crisis.
    Nderitu T
    E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.